1. Home
  2. DGX vs PODD Comparison

DGX vs PODD Comparison

Compare DGX & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$182.89

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$304.01

Market Cap

22.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGX
PODD
Founded
1967
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.5B
22.1B
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
DGX
PODD
Price
$182.89
$304.01
Analyst Decision
Buy
Strong Buy
Analyst Count
15
19
Target Price
$194.07
$359.00
AVG Volume (30 Days)
1.2M
765.6K
Earning Date
10-21-2025
11-06-2025
Dividend Yield
1.75%
N/A
EPS Growth
14.49
N/A
EPS
8.51
3.45
Revenue
$10,850,000,000.00
$2,521,800,000.00
Revenue This Year
$12.37
$32.55
Revenue Next Year
$3.52
$20.39
P/E Ratio
$21.44
$88.24
Revenue Growth
13.74
27.11
52 Week Low
$148.70
$230.05
52 Week High
$197.55
$354.88

Technical Indicators

Market Signals
Indicator
DGX
PODD
Relative Strength Index (RSI) 44.87 40.94
Support Level $184.18 $303.20
Resistance Level $185.12 $317.34
Average True Range (ATR) 3.22 13.12
MACD -0.78 -2.82
Stochastic Oscillator 3.85 3.14

Price Performance

Historical Comparison
DGX
PODD

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: